Heterogeneous induction of apoptosis in colon cancer cells by wild-type p53 gene transfection

International Journal of Oncology

Volumn 12, Issue 4, 1998, Pages 777-784

  Namoto, Masaaki ^a   Yonemitsu, Yoshikazu ^a   Nakagawa, Kazunori ^a   Hashimoto, Shuichi ^a   Kaneda, Yasufumi ^b   Nawata, Hajime ^a   Sueishi, Katsuo ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

Apoptosis; Gene therapy; Growth arrest; HVJ cationic liposome; Wild type p53

Indexed keywords

DOXORUBICIN; LIPOSOME; PROTEIN P53;

APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER INHIBITION; COLON CANCER; CONTROLLED STUDY; GENE TRANSFER; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

EID: 0031916809     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.12.4.777     Document Type: Article

References (36)

1. El-Deiry WS, Tokino T, Velculscuel VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW and Vogelstein B: WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817-825, 1993.
2. Harper JW, Adami GR, Wei N, Keyomarsi K and Elledge SJ: The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75: 805-816, 1993.
3. Noda A, Ning Y, Venables SF, Pereira-Smith OM and Smith JR: Cloning of senescent cell-derived inhibitors of DNA synthesis using expression screen. Exp Cell Res 21: 190-198, 1994.
4. Lowe SW, Ruley HE, Jacks T and Houseman DE: p53-dependent apoptosis modulates the cytotoxity of anticancer agents. Cell 74: 957-967, 1993.
5. Yonish-Rouach E, Dalia R, Lotem J, Sachs L, Kinchi A and Moshe O: Wild-type p53 induces apoptosis of myeloid leukemic cells that is inhibited by interleukin-6. Nature 35: 2345-2347, 1991.
6. Hollstein M, Sidransky D, Vogelstein B and Haris CC: p53 mutations in human cancers. Science 253: 49-53, 1991.
7. Liu TJ, El-Naggar AK, McDonnel T, Steck K, Wang M, Tayler DL and Clayman GL: Apoptosis induction mediated by wild-type p53 adenoviral gene transfer in squamous cell carcinoma of the head and neck. Cancer Res 55: 3117-3122, 1995.
8. Greenblatt MS, Bennett WP, Hollstein M and Haris CC: Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 54: 4855-4878, 1994.
9. Levine AJ, Perry ME, Chang A, Silver A, Ditimer D, Wu M and Welsh D: The role of the p53 tumor suppressor gene in tumorgenesis. The 1993 Walter Huber Lecture. Br J Cancer 69: 409-416, 1994.
10. Bennet MR, Evan GI and Schwartz SM: Apoptosis of rat vascular smooth muscle cells regulated by p53 dependent and independent pathway. Circ Res 77: 266-273, 1995.
11. Yonemitsu Y, Kaneda Y, Hata Y, Nakashima Y and Sueishi K: Wild-type p53 gene transfer: A novel therapeutic strategy for neo-intimal hyperplasia after injury. Ann NY Acad Sci (In press).
12. Roth JA, Ngyen D, Lawrence DD, Kemp BL, Carrasco CH, Ferson DZ, Hong WK, Komaki R, Lee JJ, Nesbitt JC, Pisters KMW, Putnam JB, Schea R, Shin DM, Walsh GL, Dolormente MM, Han CI, Martin FD, Yen N, Xu K, Stephens LC, McDonnel TJ, Mukhopadhyay T and Cai D: Retrovirus-mediated wild-type p53 gene transfer to tumors of patients with lung cancer. Nat Med 2: 985-991, 1996.
13. Kaneda Y, Uchida T, Kim J, Ishimura M and Okada Y: The improved efficient method for introduction macromolecules into cells using HVJ (Sendai virus) liposomes with gangilosides. Exp Cell Res 173: 56-69, 1987.
14. Yonemitsu Y, Kaneda Y, Morishita R, Nakagawa K, Nakashima Y and Sueishi K: Characterization of in vivo gene transfer into the arterial wall mediated by the HVJ (Sendai virus)-liposomes - an effective tool for the in vivo study of arterial disease. Lab Invest 75: 313-323, 1996.
15. Yonemitsu Y, Kaneda Y, Muraishi A, Yoshizumi T, Sugimachi K and Sueishi K: HVJ (Sendai virus) - cationic liposomes: a novel and potentially effective liposome-mediated gene transfer technique to the airway epithelium. Gene Ther (In press).
16. Shirasawa S: Analysis of molecular mechanism in colorectal tumorgenesis. Fukuoka Igaku Zasshi 84: 25-35, 1993.
17. Yonemitsu Y, Kaneda Y, Komori K, Hirai K, Sugimachi K and Sueishi K: The immediate early gene of human cytomegalovirus stimulates vascular smooth muscle cell proliferation in vitro and in vivo. Biochem Biophys Res Commun 231: 447-451, 1997.
18. Gavrieli Y, Sherman Y and Ben-Sasson SA: Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 3: 493-501, 1992.
19. Runnebaum IB and Kreinberg R: p53 trans-dominantly suppresses tumor formation of human breast cancer cells mediated by retroviral bulk infection without marker gene selection: an expeditious in vitro protocol with implications towards gene therapy. Hybridoma 14: 153-157, 1995.
20. Zhang WW, Fang X, Mazur W, French BA, Georges RN and Roth JA: High efficiency gene transfer and high-level expression of wild-type p53 in human lung cancer cells mediated by recombinant adenovirus. Cancer Gene Ther 1: 5-13, 1994.
21. Fujiwara T, Elizabeth AG, Mukhopadhyay T, Zhang WW, Owen-Schaub LB and Roth JA: Induction of chemosensitivity in human lung cancer cells in vivo by adenovirus-mediated transfer of the wild-type p53 gene. Cancer Res 54: 2287-2291, 1994.
22. Harris MP, Sutjipto S, Wills KN, Hancock W, Cornell D, Johnson DE, Gregory RJ, Shepard HM and Maneval DC: Adenovirus-mediated p53 gene transfer inhibits growth of human tumor cells expressing mutant p53 protein. Cancer Gene Ther 3: 121-130, 1996.
23. Shounan Y, Dolnikov A, Mackenzie KL, Miller M, Chan YY and Symonds G: Retroviral transduction of hematopoietic progenitor cells with mutant p53 promotes survival and proliferation, modifies differentiation potential and inhibits apoptosis. Leukemia 10: 1619-1628, 1996.
24. Clayman GL, El-Naggar AK, Roth JA, Zhang WW, Goepfert H, Taylor DL and Liu TJ: In vivo molecular therapy with p53 adenovirus for microscopic residual head and neck squamous carcinoma. Cancer Res 55: 1-6, 1995.
25. Reich NC and Levine AJ: Growth regulation of a cellular tumor antigen, p53, in transformed cells. Nature 308: 199-201, 1984.
26. Cirelli C, Riccinoni T, Yang C, Pili R, Gloe T and Chnag J: Adenovirus-mediated gene transfer of wild-type p53 results in melanoma cell apoptosis in vitro and in vivo. Int J Cancer 63: 673-679, 1995.
27. Hollestein M, Shomer B, Greenblatt M, Soussi T, Hovig E, Montesano R and Harris CC: Somatic point mutations in the p53 gene of human tumors and cell lines: updated compilation. Nucleic Acids Res 24: 141-146, 1996.
28. Betrand R, Sarabg M, Jenkin J, Kerrigan D and Pommier Y: Differential induction of secondary DNA fragmentation by topoisomerase II inhibitors in human tumor cell lines with amplified c-myc expression. Cancer Res 51: 6280-6285, 1991.
29. Hermeking H and Eick D: Mediation of c-Myc-induced apoptosis by p53. Science 265: 2091-2093, 1994.
30. Saito Y and Ogawa K: Wild type p53 and c-myc co-operation in generating apoptosis of a rat hepatocellular carcinoma cell line (FAA-HTC1). Oncogene 11: 1013-1018, 1995.
31. 1 arrest in human cancer cells. Cancer Res 55: 5187-5190, 1995.
32. Sato K, Schauble B, Kleihuse P and Ohgaki H: Infrequent alterations of the p15, p16, CDK4 and CYCLIN D1 genes in nonastrocytic human brain tumors. Int J Cancer 66: 305-308, 1996.
33. Fitzgerald MG, Harkin DP, Arrieta SS, MacDonald DJ, Lucchina LC, Unsal H, O'Neill E and Koh J: Prevalence of germline mutations in p16, p19ARF and CDK4 in familial melanoma: Analysis of a clinic-based population. Proc Natl Acad Sci USA 93: 8541-8545, 1996.
34. Norihiro K, Morosetti R, Miller CW, Park D, Spirin KS, Nakamaki T, Takeuchi S and Hatta Y: Molecular analysis of the cyclin-dependent kinase inhibitor gene p27/kip1 in human malignancies. Cancer Res 55: 2266-2269, 1995.
35. Aas T, Borresen AL, Geisler S, Sorensen, BS, Johsen H and Varhaug JE: Specific p53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients. Nat Med 2: 811-814, 1996.
36. Chin KV, Ueda K, Pastan I and Gottesman MM: Modulation of activity of the promoter of the human MDR1 gene by Ras and p53. Science 255: 459-462, 1994.